182 related articles for article (PubMed ID: 30577767)
1. Semaphorin-5A maintains epithelial phenotype of malignant pancreatic cancer cells.
Saxena S; Purohit A; Varney ML; Hayashi Y; Singh RK
BMC Cancer; 2018 Dec; 18(1):1283. PubMed ID: 30577767
[TBL] [Abstract][Full Text] [Related]
2. High gene expression of semaphorin 5A in pancreatic cancer is associated with tumor growth, invasion and metastasis.
Sadanandam A; Varney ML; Singh S; Ashour AE; Moniaux N; Deb S; Lele SM; Batra SK; Singh RK
Int J Cancer; 2010 Sep; 127(6):1373-83. PubMed ID: 20073063
[TBL] [Abstract][Full Text] [Related]
3. Secreted semaphorin 5A suppressed pancreatic tumour burden but increased metastasis and endothelial cell proliferation.
Sadanandam A; Sidhu SS; Wullschleger S; Singh S; Varney ML; Yang CS; Ashour AE; Batra SK; Singh RK
Br J Cancer; 2012 Jul; 107(3):501-7. PubMed ID: 22782341
[TBL] [Abstract][Full Text] [Related]
4. Pathological and functional significance of Semaphorin-5A in pancreatic cancer progression and metastasis.
Saxena S; Hayashi Y; Wu L; Awaji M; Atri P; Varney ML; Purohit A; Rachagani S; Batra SK; Singh RK
Oncotarget; 2018 Jan; 9(5):5931-5943. PubMed ID: 29464045
[TBL] [Abstract][Full Text] [Related]
5. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
[TBL] [Abstract][Full Text] [Related]
6. Role of BCL9L in transforming growth factor-β (TGF-β)-induced epithelial-to-mesenchymal-transition (EMT) and metastasis of pancreatic cancer.
Sannino G; Armbruster N; Bodenhöfer M; Haerle U; Behrens D; Buchholz M; Rothbauer U; Sipos B; Schmees C
Oncotarget; 2016 Nov; 7(45):73725-73738. PubMed ID: 27713160
[TBL] [Abstract][Full Text] [Related]
7. Stabilized epithelial phenotype of cancer cells in primary tumors leads to increased colonization of liver metastasis in pancreatic cancer.
Carstens JL; Yang S; Correa de Sampaio P; Zheng X; Barua S; McAndrews KM; Rao A; Burks JK; Rhim AD; Kalluri R
Cell Rep; 2021 Apr; 35(2):108990. PubMed ID: 33852841
[TBL] [Abstract][Full Text] [Related]
8. Deguelin suppresses pancreatic tumor growth and metastasis by inhibiting epithelial-to-mesenchymal transition in an orthotopic model.
Boreddy SR; Srivastava SK
Oncogene; 2013 Aug; 32(34):3980-91. PubMed ID: 22986522
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of GP73 promotes cell invasion, migration and metastasis by inducing epithelial-mesenchymal transition in pancreatic cancer.
Song YX; Xu ZC; Li HL; Yang PL; Du JK; Xu J
Pancreatology; 2018 Oct; 18(7):812-821. PubMed ID: 30217697
[TBL] [Abstract][Full Text] [Related]
10. MiR-652 inhibits acidic microenvironment-induced epithelial-mesenchymal transition of pancreatic cancer cells by targeting ZEB1.
Deng S; Li X; Niu Y; Zhu S; Jin Y; Deng S; Chen J; Liu Y; He C; Yin T; Yang Z; Tao J; Xiong J; Wu H; Wang C; Zhao G
Oncotarget; 2015 Nov; 6(37):39661-75. PubMed ID: 26498682
[TBL] [Abstract][Full Text] [Related]
11. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
12. Semaphorin 5A suppresses the proliferation and migration of lung adenocarcinoma cells.
Ko PH; Lenka G; Chen YA; Chuang EY; Tsai MH; Sher YP; Lai LC
Int J Oncol; 2020 Jan; 56(1):165-177. PubMed ID: 31789397
[TBL] [Abstract][Full Text] [Related]
13. TUFT1 regulates metastasis of pancreatic cancer through HIF1-Snail pathway induced epithelial-mesenchymal transition.
Zhou B; Zhan H; Tin L; Liu S; Xu J; Dong Y; Li X; Wu L; Guo W
Cancer Lett; 2016 Nov; 382(1):11-20. PubMed ID: 27566398
[TBL] [Abstract][Full Text] [Related]
14. Response gene to complement-32 enhances metastatic phenotype by mediating transforming growth factor beta-induced epithelial-mesenchymal transition in human pancreatic cancer cell line BxPC-3.
Zhu L; Qin H; Li PY; Xu SN; Pang HF; Zhao HZ; Li DM; Zhao Q
J Exp Clin Cancer Res; 2012 Mar; 31(1):29. PubMed ID: 22458379
[TBL] [Abstract][Full Text] [Related]
15. IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway.
Yadav A; Kumar B; Datta J; Teknos TN; Kumar P
Mol Cancer Res; 2011 Dec; 9(12):1658-67. PubMed ID: 21976712
[TBL] [Abstract][Full Text] [Related]
16. CUL4B promotes metastasis and proliferation in pancreatic cancer cells by inducing epithelial-mesenchymal transition via the Wnt/β-catenin signaling pathway.
He YM; Xiao YS; Wei L; Zhang JQ; Peng CH
J Cell Biochem; 2018 Jul; 119(7):5308-5323. PubMed ID: 29274277
[TBL] [Abstract][Full Text] [Related]
17. SNAIL induces epithelial-to-mesenchymal transition in a human pancreatic cancer cell line (BxPC3) and promotes distant metastasis and invasiveness in vivo.
Nishioka R; Itoh S; Gui T; Gai Z; Oikawa K; Kawai M; Tani M; Yamaue H; Muragaki Y
Exp Mol Pathol; 2010 Oct; 89(2):149-57. PubMed ID: 20576520
[TBL] [Abstract][Full Text] [Related]
18. Knockdown of FOXO3a induces epithelial-mesenchymal transition and promotes metastasis of pancreatic ductal adenocarcinoma by activation of the β-catenin/TCF4 pathway through SPRY2.
Li J; Yang R; Dong Y; Chen M; Wang Y; Wang G
J Exp Clin Cancer Res; 2019 Jan; 38(1):38. PubMed ID: 30691517
[TBL] [Abstract][Full Text] [Related]
19. Semaphorin 5A drives melanoma progression: role of Bcl-2, miR-204 and c-Myb.
D'Aguanno S; Valentini E; Tupone MG; Desideri M; Di Martile M; Spagnuolo M; Buglioni S; Ercolani C; Falcone I; De Dominici M; Milella M; Rizzo MG; Calabretta B; Cota C; Anichini A; Trisciuoglio D; Del Bufalo D
J Exp Clin Cancer Res; 2018 Nov; 37(1):278. PubMed ID: 30454024
[TBL] [Abstract][Full Text] [Related]
20. Mouse double minute 2 (MDM2) upregulates Snail expression and induces epithelial-to-mesenchymal transition in breast cancer cells in vitro and in vivo.
Lu X; Yan C; Huang Y; Shi D; Fu Z; Qiu J; Yin Y
Oncotarget; 2016 Jun; 7(24):37177-37191. PubMed ID: 27184007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
